新維國際(08086.HK)訂保健產品及健康食品戰略合作框架
新維國際(08086.HK)公布,於5月13日與合作夥伴浙江綠泰訂立不具法律約束力戰略合作框架協議。
合作夥伴擬自行或通過其聯營品牌研發更多保健產品及健康食品,及提供線下藥房、線上電子商務及其他銷售網絡,公司則將允許合作夥伴的產品在其網上銷售平台或集團的其他網上銷售平台上銷售。
公司認為,引入合作夥伴作為戰略夥伴將進一步發展及擴大網上銷售平台的銷量及於中國帶來有效的推廣效果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.